The future management of mantle cell lymphoma
The future management of mantle cell lymphoma
MCL is an aggressive B cell malignancy which is incurable with standard therapies. In this video, the current standard o... Read more
30 Aug 2013
•
16mins
Multiple myeloma: Non-transplant candidates
Multiple myeloma: Non-transplant candidates
Treating elderly MM patients is challenging because of the heterogeneity of this patient population. This needs to be ta... Read more
30 Aug 2013
•
10mins
Similar Podcasts
Blood & Cancer
blooducation's podcast
VJHemOnc Podcast
Blood Advances Talks
Treating Blood Cancers
Hematology Lecture's Podcast
PeerView Oncology & Hematology CME/CNE/CPE Video Podcast
Leukemia CancerCare Connect Education Workshops
PeerVoice Oncology & Haematology Audio
The Hematologist
Blood Podcast
PeerView Oncology & Hematology CME/CNE/CPE Audio Podcast
Cancer Grand Rounds Lectures from the Norris Cotton Cancer Center Podcasts
Outspoken Oncology
The ASCO Post Podcast
Relapsed multiple myeloma patients
Relapsed multiple myeloma patients
In patients with biochemical relapse with a small increase in M protein levels in the serum or urine, treatment is not i... Read more
30 Aug 2013
•
9mins
Transplant multiple myeloma candidate
Transplant multiple myeloma candidate
Induction regimen for transplant eligible multiple myeloma (MM) patients is 4-6 course of a triple drug regimen, typical... Read more
30 Aug 2013
•
16mins
Most Popular Podcasts
The Joe Rogan Experience
TED Talks Daily
The Tim Ferriss Show
The Daily
Stuff You Should Know
Oprah's SuperSoul Conversations
Armchair Expert with Dax Shepard
Advances in Multiple Myeloma from EHA 2013
Advances in Multiple Myeloma from EHA 2013
Multiple myeloma (MM) is the second most common haematological cancer. There is no cure and the 5-year relative survival... Read more
30 Aug 2013
•
17mins
Chronic lymphocytic leukaemia update from EHA 2013
Chronic lymphocytic leukaemia update from EHA 2013
Chronic lymphocytic leukaemia (CLL) is the most common leukaemia in Europe. It is most frequently diagnosed in elderly p... Read more
30 Aug 2013
•
17mins
Pomalidomide prolongs survival in refractory multiple myeloma patients
Pomalidomide prolongs survival in refractory multiple myeloma patients
Prof Jesus San Miguel talks with ecancer at the 18th EHA Congress about the MM-003 trial.MM-003 is a large, multi-centre... Read more
29 Aug 2013
•
7mins
Carfilzomib plus melphalanprednisone in elderly patients with newly diagnosed multiple myeloma
Carfilzomib plus melphalanprednisone in elderly patients with newly diagnosed multiple myeloma
Prof Philippe Moreau talks to ecancer at the 18th EHA Congress about the results of a phase I/II trial that tested carfi... Read more
29 Aug 2013
•
2mins
